{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T08:32:37Z","timestamp":1793176357020,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"The Tou-Yan Innovation Team Program of the Heilongjiang Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Cell Biol"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1038\/s41556-025-01753-3","type":"journal-article","created":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:04:38Z","timestamp":1757408678000},"page":"1555-1571","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["CD160 dictates anti-PD-1 immunotherapy resistance by regulating CD8+ T cell exhaustion in colorectal cancer"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7539-3924","authenticated-orcid":false,"given":"Tongsen","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2461-7756","authenticated-orcid":false,"given":"Chujie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3806-6442","authenticated-orcid":false,"given":"Shihui","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7040-5260","authenticated-orcid":false,"given":"Yang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-6612-8204","authenticated-orcid":false,"given":"Cheng","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-2364","authenticated-orcid":false,"given":"Jiaqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1831-2737","authenticated-orcid":false,"given":"Hongxue","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjian","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-6710","authenticated-orcid":false,"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3205-0988","authenticated-orcid":false,"given":"Te","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2985-0629","authenticated-orcid":false,"given":"Feng","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-371X","authenticated-orcid":false,"given":"Dapeng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0249-0581","authenticated-orcid":false,"given":"Xue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,9]]},"reference":[{"key":"1753_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel, R. L., Miller, K. D., Wagle, N. S. & Jemal, A. Cancer statistics, 2023. CA Cancer J. Clin. 73, 17\u201348 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"1753_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41586-024-08216-z","volume":"636","author":"T Mayassi","year":"2024","unstructured":"Mayassi, T. et al. Spatially restricted immune and microbiota-driven adaptation of the gut. Nature 636, 447\u2013456 (2024).","journal-title":"Nature"},{"key":"1753_CR3","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0140-6736(73)91228-2","volume":"1","author":"AB Lowenfels","year":"1973","unstructured":"Lowenfels, A. B. Why are small-bowel tumours so rare? Lancet 1, 24\u201326 (1973).","journal-title":"Lancet"},{"key":"1753_CR4","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nri3738","volume":"14","author":"AM Mowat","year":"2014","unstructured":"Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667\u2013685 (2014).","journal-title":"Nat. Rev. Immunol."},{"key":"1753_CR5","doi-asserted-by":"publisher","first-page":"2398126","DOI":"10.1080\/19490976.2024.2398126","volume":"16","author":"H Anandakumar","year":"2024","unstructured":"Anandakumar, H. et al. Segmental patterning of microbiota and immune cells in the murine intestinal tract. Gut Microbes 16, 2398126 (2024).","journal-title":"Gut Microbes"},{"key":"1753_CR6","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.abj8695","volume":"377","author":"BS Reis","year":"2022","unstructured":"Reis, B. S. et al. TCR-V\u03b3\u03b4 usage distinguishes protumor from antitumor intestinal \u03b3\u03b4 T cell subsets. Science 377, 276\u2013284 (2022).","journal-title":"Science"},{"key":"1753_CR7","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jcmgh.2021.01.014","volume":"11","author":"R Morikawa","year":"2021","unstructured":"Morikawa, R. et al. Intraepithelial lymphocytes suppress intestinal tumor growth by cell-to-cell contact via CD103\/E-cadherin signal. Cell Mol. Gastroenterol. Hepatol. 11, 1483\u20131503 (2021).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"1753_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adf2163","volume":"8","author":"MH Yakou","year":"2023","unstructured":"Yakou, M. H. et al. TCF-1 limits intraepithelial lymphocyte antitumor immunity in colorectal carcinoma. Sci. Immunol. 8, eadf2163 (2023).","journal-title":"Sci. Immunol."},{"key":"1753_CR9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.immuni.2022.12.007","volume":"56","author":"YH Lin","year":"2023","unstructured":"Lin, Y. H. et al. Small intestine and colon tissue-resident memory CD8+ T cells exhibit molecular heterogeneity and differential dependence on Eomes. Immunity 56, 207\u2013223.e8 (2023).","journal-title":"Immunity"},{"key":"1753_CR10","doi-asserted-by":"publisher","first-page":"2768","DOI":"10.3389\/fimmu.2019.02768","volume":"10","author":"PD Pioli","year":"2019","unstructured":"Pioli, P. D. Plasma cells, the next generation: beyond antibody secretion. Front. Immunol. 10, 2768 (2019).","journal-title":"Front. Immunol."},{"key":"1753_CR11","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/cells10061270","volume":"10","author":"JN Lichterman","year":"2021","unstructured":"Lichterman, J. N. & Reddy, S. M. Mast cells: a new frontier for cancer immunotherapy. Cells 10, 1270 (2021).","journal-title":"Cells"},{"key":"1753_CR12","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41586-018-0694-x","volume":"564","author":"L Zhang","year":"2018","unstructured":"Zhang, L. et al. Lineage tracking reveals dynamic relationships of T cells in colorectal cancer. Nature 564, 268\u2013272 (2018).","journal-title":"Nature"},{"key":"1753_CR13","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0016-5085(90)91025-2","volume":"99","author":"MC Allison","year":"1990","unstructured":"Allison, M. C., Poulter, L. W., Dhillon, A. P. & Pounder, R. E. Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa. Comparison of follicular and lamina propria lymphocytes. Gastroenterology 99, 421\u2013430 (1990).","journal-title":"Gastroenterology"},{"key":"1753_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0165-2478(92)90192-Q","volume":"32","author":"LK Trejdosiewicz","year":"1992","unstructured":"Trejdosiewicz, L. K. Intestinal intraepithelial lymphocytes and lymphoepithelial interactions in the human gastrointestinal mucosa. Immunol. Lett. 32, 13\u201319 (1992).","journal-title":"Immunol. Lett."},{"key":"1753_CR15","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1038\/s41591-020-1003-4","volume":"26","author":"D Corridoni","year":"2020","unstructured":"Corridoni, D. et al. Single-cell atlas of colonic CD8+ T cells in ulcerative colitis. Nat. Med. 26, 1480\u20131490 (2020).","journal-title":"Nat. Med."},{"key":"1753_CR16","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-023-02371-y","volume":"29","author":"Y Chu","year":"2023","unstructured":"Chu, Y. et al. Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance. Nat. Med. 29, 1550\u20131562 (2023).","journal-title":"Nat. Med."},{"key":"1753_CR17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science 374, abe6474 (2021).","journal-title":"Science"},{"key":"1753_CR18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1126\/science.abl5447","volume":"375","author":"FJ Lowery","year":"2022","unstructured":"Lowery, F. J. et al. Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers. Science 375, 877\u2013884 (2022).","journal-title":"Science"},{"key":"1753_CR19","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1038\/s41591-023-02497-z","volume":"29","author":"M Thibaudin","year":"2023","unstructured":"Thibaudin, M. et al. First-line durvalumab and tremelimumab with chemotherapy in RAS-mutated metastatic colorectal cancer: a phase 1b\/2 trial. Nat. Med. 29, 2087\u20132098 (2023).","journal-title":"Nat. Med."},{"key":"1753_CR20","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell 41, 1852\u20131870.e9 (2023).","journal-title":"Cancer Cell"},{"key":"1753_CR21","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1002\/JLB.5MR0722-777R","volume":"112","author":"D Chen","year":"2022","unstructured":"Chen, D. et al. \u03b3\u03b4 T cell exhaustion: opportunities for intervention. J. Leukoc. Biol. 112, 1669\u20131676 (2022).","journal-title":"J. Leukoc. Biol."},{"key":"1753_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."},{"key":"1753_CR23","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.cell.2018.10.038","volume":"175","author":"M Sade-Feldman","year":"2018","unstructured":"Sade-Feldman, M. et al. Defining T cell states associated with response to checkpoint immunotherapy in melanoma. Cell 175, 998\u20131013.e20 (2018).","journal-title":"Cell"},{"key":"1753_CR24","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1126\/science.1229620","volume":"338","author":"MA Paley","year":"2012","unstructured":"Paley, M. A. et al. Progenitor and terminal subsets of CD8+ T cells cooperate to contain chronic viral infection. Science 338, 1220\u20131225 (2012).","journal-title":"Science"},{"key":"1753_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abm6931","volume":"7","author":"GY Seo","year":"2022","unstructured":"Seo, G. Y. et al. Epithelial HVEM maintains intraepithelial T cell survival and contributes to host protection. Sci. Immunol. 7, eabm6931 (2022).","journal-title":"Sci. Immunol."},{"key":"1753_CR26","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1002\/eji.200635935","volume":"36","author":"J Rey","year":"2006","unstructured":"Rey, J. et al. The co-expression of 2B4 (CD244) and CD160 delineates a subpopulation of human CD8+ T cells with a potent CD160-mediated cytolytic effector function. Eur. J. Immunol. 36, 2359\u20132366 (2006).","journal-title":"Eur. J. Immunol."},{"key":"1753_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.trsl.2016.09.004","volume":"181","author":"ML Del Rio","year":"2017","unstructured":"Del Rio, M. L. et al. Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier. Transl. Res. 181, 83\u201395.e3 (2017).","journal-title":"Transl. Res."},{"key":"1753_CR28","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.ccell.2023.03.009","volume":"41","author":"JA Pai","year":"2023","unstructured":"Pai, J. A. et al. Lineage tracing reveals clonal progenitors and long-term persistence of tumor-specific T cells during immune checkpoint blockade. Cancer Cell 41, 776\u2013790.e7 (2023).","journal-title":"Cancer Cell"},{"key":"1753_CR29","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li, J. et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell 41, 1152\u20131169.e7 (2023).","journal-title":"Cancer Cell"},{"key":"1753_CR30","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ccell.2022.06.001","volume":"40","author":"JA Belk","year":"2022","unstructured":"Belk, J. A. et al. Genome-wide CRISPR screens of T cell exhaustion identify chromatin remodeling factors that limit T cell persistence. Cancer Cell 40, 768\u2013786.e7 (2022).","journal-title":"Cancer Cell"},{"key":"1753_CR31","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ccell.2023.02.005","volume":"41","author":"JD Klement","year":"2023","unstructured":"Klement, J. D. et al. Tumor PD-L1 engages myeloid PD-1 to suppress type I interferon to impair cytotoxic T lymphocyte recruitment. Cancer Cell 41, 620\u2013636.e9 (2023).","journal-title":"Cancer Cell"},{"key":"1753_CR32","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/s41590-019-0312-6","volume":"20","author":"BC Miller","year":"2019","unstructured":"Miller, B. C. et al. Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade. Nat. Immunol. 20, 326\u2013336 (2019).","journal-title":"Nat. Immunol."},{"key":"1753_CR33","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","volume":"45","author":"DT Utzschneider","year":"2016","unstructured":"Utzschneider, D. T. et al. T cell factor 1-expressing memory-like CD8+ T cells sustain the immune response to chronic viral infections. Immunity 45, 415\u2013427 (2016).","journal-title":"Immunity"},{"key":"1753_CR34","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa2017699","volume":"383","author":"T Andr\u00e9","year":"2020","unstructured":"Andr\u00e9, T. et al. Pembrolizumab in microsatellite-instability-high advanced colorectal cancer. N. Engl. J. Med. 383, 2207\u20132218 (2020).","journal-title":"N. Engl. J. Med."},{"key":"1753_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-50266-4","volume":"15","author":"C Huang","year":"2024","unstructured":"Huang, C. et al. Antibody Fc-receptor Fc\u03b5R1\u03b3 stabilizes cell surface receptors in group 3 innate lymphoid cells and promotes anti-infection immunity. Nat. Commun. 15, 5981 (2024).","journal-title":"Nat. Commun."},{"key":"1753_CR36","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.4049\/jimmunol.2200792","volume":"211","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. CD160 signaling is essential for CD8+ T cell memory formation via upregulation of 4-1BB. J. Immunol. 211, 1367\u20131375 (2023).","journal-title":"J. Immunol."},{"key":"1753_CR37","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1182\/blood-2007-10-115220","volume":"111","author":"K Pichler","year":"2008","unstructured":"Pichler, K. et al. Strong induction of 4-1BB, a growth and survival promoting costimulatory receptor, in HTLV-1-infected cultured and patients\u2019 T cells by the viral Tax oncoprotein. Blood 111, 4741\u20134751 (2008).","journal-title":"Blood"},{"key":"1753_CR38","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo, Q. et al. NF-\u03baB in biology and targeted therapy: new insights and translational implications. Signal Transduct. Target Ther. 9, 53 (2024).","journal-title":"Signal Transduct. Target Ther."},{"key":"1753_CR39","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jare.2023.04.007","volume":"57","author":"S Shen","year":"2024","unstructured":"Shen, S. et al. The exoprotein Gbp of Fusobacterium nucleatum promotes THP-1 cell lipid deposition by binding to CypA and activating PI3K-AKT\/MAPK\/NF-\u03baB pathways. J. Adv. Res. 57, 93\u2013105 (2024).","journal-title":"J. Adv. Res."},{"key":"1753_CR40","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/s43018-021-00218-4","volume":"2","author":"P Castel","year":"2021","unstructured":"Castel, P., Toska, E., Engelman, J. A. & Scaltriti, M. The present and future of PI3K inhibitors for cancer therapy. Nat. Cancer 2, 587\u2013597 (2021).","journal-title":"Nat. Cancer"},{"key":"1753_CR41","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1001\/jamaoncol.2017.1051","volume":"3","author":"AB Schrock","year":"2017","unstructured":"Schrock, A. B. et al. Genomic profiling of small-bowel adenocarcinoma. JAMA Oncol. 3, 1546\u20131553 (2017).","journal-title":"JAMA Oncol."},{"key":"1753_CR42","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/j.immuni.2023.01.002","volume":"56","author":"L Kong","year":"2023","unstructured":"Kong, L. et al. The landscape of immune dysregulation in Crohn\u2019s disease revealed through single-cell transcriptomic profiling in the ileum and colon. Immunity 56, 444\u2013458.e5 (2023).","journal-title":"Immunity"},{"key":"1753_CR43","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.cell.2017.08.046","volume":"171","author":"DP Hoytema van Konijnenburg","year":"2017","unstructured":"Hoytema van Konijnenburg, D. P. et al. Intestinal epithelial and intraepithelial T cell crosstalk mediates a dynamic response to infection. Cell 171, 783\u2013794.e13 (2017).","journal-title":"Cell"},{"key":"1753_CR44","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1146\/annurev-immunol-101921-045939","volume":"41","author":"W Chen","year":"2023","unstructured":"Chen, W. TGF-\u03b2 regulation of T cells. Annu. Rev. Immunol. 41, 483\u2013512 (2023).","journal-title":"Annu. Rev. Immunol."},{"key":"1753_CR45","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1084\/jem.20041044","volume":"201","author":"R El-Asady","year":"2005","unstructured":"El-Asady, R. et al. TGF-\u03b2-dependent CD103 expression by CD8+ T cells promotes selective destruction of the host intestinal epithelium during graft-versus-host disease. J. Exp. Med. 201, 1647\u20131657 (2005).","journal-title":"J. Exp. Med."},{"key":"1753_CR46","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.4049\/jimmunol.161.6.2780","volume":"161","author":"A Anumanthan","year":"1998","unstructured":"Anumanthan, A. et al. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161, 2780\u20132790 (1998).","journal-title":"J. Immunol."},{"key":"1753_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/ni1554","volume":"9","author":"G Cai","year":"2008","unstructured":"Cai, G. et al. CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat. Immunol. 9, 176\u2013185 (2008).","journal-title":"Nat. Immunol."},{"key":"1753_CR48","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.3389\/fimmu.2020.02188","volume":"11","author":"L Zhang","year":"2020","unstructured":"Zhang, L. et al. CD160 plays a protective role during chronic infection by enhancing both functionalities and proliferative capacity of CD8+ T cells. Front. Immunol. 11, 2188 (2020).","journal-title":"Front. Immunol."},{"key":"1753_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1084\/jem.20131601","volume":"212","author":"TC Tu","year":"2015","unstructured":"Tu, T. C. et al. CD160 is essential for NK-mediated IFN-\u03b3 production. J. Exp. Med. 212, 415\u2013429 (2015).","journal-title":"J. Exp. Med."},{"key":"1753_CR50","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1158\/0008-5472.CAN-18-1049","volume":"78","author":"H Sun","year":"2018","unstructured":"Sun, H. et al. Reduced CD160 expression contributes to impaired NK-cell function and poor clinical outcomes in patients with HCC. Cancer Res. 78, 6581\u20136593 (2018).","journal-title":"Cancer Res."},{"key":"1753_CR51","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/s41591-019-0522-3","volume":"25","author":"KE Yost","year":"2019","unstructured":"Yost, K. E. et al. Clonal replacement of tumor-specific T cells following PD-1 blockade. Nat. Med. 25, 1251\u20131259 (2019).","journal-title":"Nat. Med."},{"key":"1753_CR52","doi-asserted-by":"publisher","first-page":"4699","DOI":"10.1158\/1078-0432.CCR-19-4110","volume":"26","author":"G Rao","year":"2020","unstructured":"Rao, G. et al. Anti\u2013PD-1 induces M1 polarization in the glioma microenvironment and exerts therapeutic efficacy in the absence of CD8 cytotoxic T cells. Clin. Cancer Res. 26, 4699\u20134712 (2020).","journal-title":"Clin. Cancer Res."},{"key":"1753_CR53","doi-asserted-by":"publisher","first-page":"112437","DOI":"10.1016\/j.celrep.2023.112437","volume":"42","author":"Q Luo","year":"2023","unstructured":"Luo, Q. et al. Apatinib remodels the immunosuppressive tumor ecosystem of gastric cancer enhancing anti-PD-1 immunotherapy. Cell Rep. 42, 112437 (2023).","journal-title":"Cell Rep."},{"key":"1753_CR54","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nature22396","volume":"545","author":"SR Gordon","year":"2017","unstructured":"Gordon, S. R. et al. PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity. Nature 545, 495\u2013499 (2017).","journal-title":"Nature"},{"key":"1753_CR55","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.cell.2023.03.007","volume":"186","author":"D Hirschhorn","year":"2023","unstructured":"Hirschhorn, D. et al. T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants. Cell 186, 1432\u20131447.e17 (2023).","journal-title":"Cell"},{"key":"1753_CR56","doi-asserted-by":"publisher","first-page":"e009603","DOI":"10.1136\/jitc-2024-009603","volume":"12","author":"J Wang","year":"2024","unstructured":"Wang, J. et al. Intratumoral CXCL13+ CD160+ CD8+ T cells promote the formation of tertiary lymphoid structures to enhance the efficacy of immunotherapy in advanced gastric cancer. J. Immunother. Cancer 12, e009603 (2024).","journal-title":"J. Immunother. Cancer"},{"key":"1753_CR57","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1158\/1078-0432.CCR-23-2213","volume":"30","author":"J Li","year":"2024","unstructured":"Li, J. et al. Biomarkers of pathologic complete response to neoadjuvant immunotherapy in mismatch repair-deficient colorectal cancer. Clin. Cancer Res. 30, 368\u2013378 (2024).","journal-title":"Clin. Cancer Res."},{"key":"1753_CR58","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1111\/cas.15804","volume":"114","author":"J Liao","year":"2023","unstructured":"Liao, J. et al. Plasma extracellular vesicle transcriptomics identifies CD160 for predicting immunochemotherapy efficacy in lung cancer. Cancer Sci. 114, 2774\u20132786 (2023).","journal-title":"Cancer Sci."},{"key":"1753_CR59","doi-asserted-by":"publisher","first-page":"e002189","DOI":"10.1136\/jitc-2020-002189","volume":"9","author":"N Bozorgmehr","year":"2021","unstructured":"Bozorgmehr, N. et al. Expanded antigen-experienced CD160+CD8+ effector T cells exhibit impaired effector functions in chronic lymphocytic leukemia. J. Immunother. Cancer 9, e002189 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"1753_CR60","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/intimm\/dxm005","volume":"19","author":"M Rabot","year":"2007","unstructured":"Rabot, M. et al. CD160-activating NK cell effector functions depend on the phosphatidylinositol 3-kinase recruitment. Int. Immunol. 19, 401\u2013409 (2007).","journal-title":"Int. Immunol."},{"key":"1753_CR61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35096-6","volume":"13","author":"Q Sui","year":"2022","unstructured":"Sui, Q. et al. Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer. Nat. Commun. 13, 7316 (2022).","journal-title":"Nat. Commun."},{"key":"1753_CR62","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02424-0","volume":"9","author":"M Efremova","year":"2018","unstructured":"Efremova, M. et al. Targeting immune checkpoints potentiates immunoediting and changes the dynamics of tumor evolution. Nat. Commun. 9, 32 (2018).","journal-title":"Nat. Commun."},{"key":"1753_CR63","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1136\/gutjnl-2023-329543","volume":"72","author":"W Fong","year":"2023","unstructured":"Fong, W. et al. Lactobacillus gallinarum-derived metabolites boost anti-PD1 efficacy in colorectal cancer by inhibiting regulatory T cells through modulating IDO1\/Kyn\/AHR axis. Gut 72, 2272\u20132285 (2023).","journal-title":"Gut"},{"key":"1753_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-190","volume":"15","author":"JC Castle","year":"2014","unstructured":"Castle, J. C. et al. Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma. BMC Genomics 15, 190 (2014).","journal-title":"BMC Genomics"},{"key":"1753_CR65","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu, J. et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell 173, 400\u2013416.e11 (2018).","journal-title":"Cell"},{"key":"1753_CR66","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genomics Proteomics Bioinformatics 19, 578\u2013583 (2021).","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"1753_CR67","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2024. Nucleic Acids Res. 52, D18\u2013D32 (2024)."},{"key":"1753_CR68","doi-asserted-by":"publisher","unstructured":"Lyu, C. Single cell RNASeq data in colorectal cancer. Mendeley Data, V1 https:\/\/doi.org\/10.17632\/6czch25jyb.1 (2025).","DOI":"10.17632\/6czch25jyb.1"},{"key":"1753_CR69","doi-asserted-by":"publisher","unstructured":"Lyu, C. Bulk RNASeq data in colorectal cancer. Mendeley Data, V1 https:\/\/doi.org\/10.17632\/hb9jjk2gbz.1 (2025).","DOI":"10.17632\/hb9jjk2gbz.1"},{"key":"1753_CR70","doi-asserted-by":"publisher","unstructured":"Lyu, C. Bulk RNASeq data from mouse spleens. Mendeley Data, V1 https:\/\/doi.org\/10.17632\/7tgb8gnb8f.1 (2025).","DOI":"10.17632\/7tgb8gnb8f.1"}],"container-title":["Nature Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01753-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01753-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T07:02:54Z","timestamp":1757746974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41556-025-01753-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":70,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["1753"],"URL":"https:\/\/doi.org\/10.1038\/s41556-025-01753-3","relation":{},"ISSN":["1465-7392","1476-4679"],"issn-type":[{"value":"1465-7392","type":"print"},{"value":"1476-4679","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"30 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}